Veterans’ RightsAn independent resource for veterans
← All decisions
Granted

The Veteran's pseudofolliculitis barbae is now rated as 60 percent disabling, which is the maximum schedular rating permitted under Diagnostic Code (DC) 7806. The appeal for a higher rating than 60 percent has been denied.

The deciding factor: The Veteran's use of retinoids on a constant or near constant basis qualifies him for a 60 percent rating under DC 7806, but the evidence does not show he meets the criteria for a higher rating based on visible or palpable tissue loss and characteristics of disfigurement.

Claimed conditions
pseudofolliculitis barbae
How they argued it
Direct service connection
Exposure basis
None
Rating assigned
60%
Decision date
August 26, 2024
Citation
A24050013

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation A24050013.

What this means for you

A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.